@article{1b83b3ae96b74b1f8ab09446b8f603ca,
title = "COVID-19 Pandemic and Surgical Oncology: Preserving the Academic Mission",
abstract = "Background: The global pandemic of respiratory disease cause by the novel human coronavirus (SARS-CoV-2) has caused untold suffering, loss of life and upheaval in society. The pandemic has lead to massive redirection of health care resources to treat the surge of COVID-19 patients, and enforcement of social distancing to reduce the rate of transmission. Methods: Editorial Board members provided observations of the implications of the pandemic on academic surgical oncology. Results: Delivery of health care to other populations including cancer patients has been significantly disrupted. The implications both short term and long term threaten preservation of the academic mission in medicine at large, and certainly in the field of surgical oncology. Conclusions: The effects on surgical oncology training, research and clinical trials are major.",
author = "Pawlik, {Timothy M.} and Tyler, {Douglas S.} and Baran Sumer and Funda Meric-Bernstam and Okereke, {Ikenna C.} and Beane, {Joal D.} and Dedhia, {Priya H.} and Aslam Ejaz and McMasters, {Kelly M.} and Tanabe, {Kenneth K.}",
note = "Funding Information: Dr. Funda Meric-Bernstam reports receiving grant and financial support from Aileron Therapeutics, Inc., AstraZeneca, Bayer Healthcare Pharmaceutical, Calithera Biosciences Inc., Curis Inc., CytomX Therapeutics Inc., Daiichi Sankyo Co. Ltd., Debiopharm International, eFFECTOR Therapeutics, Genentech Inc., Guardant Health Inc., Millennium Pharmaceuticals Inc., Novartis, Puma Biotechnology Inc., and Taiho Pharmaceutical Co., in addition to consulting/advisory board relationships with Aduro BioTech Inc., DebioPharm, eFFECTOR Therapeutics, F. Hoffman-La Roche Ltd, Genentech Inc., IBM Watson, Jackson Laboratory, Kolon Life Science, OrigiMed, PACT Pharma, Parexel International, Pfizer Inc., Samsung Bioepis, Seattle Genetics Inc., Tyra Biosciences, Xencor, Zymeworks, Immunomedics, Inflection Biosciences, Mersana Therapeutics, Puma Biotechnology Inc., Seattle Genetics, Silverback Therapeutics, and Spectrum Pharmaceuticals. Timothy M. Pawlik, Douglas S. Tyler, Baran Sumer, Ikenna C. Okereke, Joal D. Beane, Priya H. Dedhia, Aslam Ejaz, Kelly M. McMasters, and Kenneth K. Tanabe have no conflicts to disclose. ",
year = "2020",
month = aug,
day = "1",
doi = "10.1245/s10434-020-08563-x",
language = "English (US)",
volume = "27",
pages = "2591--2599",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "8",
}